Jubilant Life Sciences has informed that 7,650 options under Jubilant Employees Stock Option Plan 2005 (Plan 2005) and 49,344 options under JLL Employees Stock Option Plan 2011 (Plan 2011) have been exercised by the option holders. Pursuant to the terms of Plan 2005 and Plan 2011, the Nomination, Remuneration and Compensation Committee of the Company has approved, on December 18, 2015, transfer of 87,594 equity shares of Re 1 each of Jubilant Life Sciences Limited from Jubilant Employees Welfare Trust to the eligible option holders. Further, pursuant to the provisions of Plan 2005 read with the Scheme of Amalgamation and Demerger between the Company, Speciality Molecules Limited, Pace Marketing Specialities Limited and Jubilant Industries Limited (JIL), the Committee has also approved transfer of 1,912 equity shares of Rs10 each of JIL to the eligible option holders.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: